Tokyo Tape
Sign in
← Genova

Half-year report · Q2

9341.TEDINET S100URJX
Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥5.1bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥8.7bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥4.0bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥1.2bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥970m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥1.2bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥2.3bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥971m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥1.2bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥971m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥815m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.7bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥626m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥815m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥629m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥8.6bnat 2024-09-30Cons.Assets
Total assets¥8.2bnat 2024-03-31Cons.Assets
Total assets¥6.3bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥1.7bnat 2024-09-30Cons.Liabilities
Total liabilities¥2.2bnat 2024-03-31Cons.Liabilities
Net assets / equity¥6.9bnat 2024-09-30Cons.Net assets
Net assets / equity¥6.0bnat 2024-03-31Cons.Net assets
Net assets / equity¥4.8bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥6.0bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥6.0bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥6.0bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥6.0bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥4.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥3.9bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥589m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.8bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥577m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥232m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥94m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥126m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥336m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥377m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥107m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥45.792024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥97.352023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.372023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥45.442024-04-01 → 2024-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥96.52023-04-01 → 2024-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥35.082023-04-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio76.7%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.5%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio74.6%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 32
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥271m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥271m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥64m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥964m
jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥3.2bn
jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥3.2bn
jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥1.7bn
jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥1.7bn
jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.7bn
jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥394m
—segment totalrevenue2024-04-01 → 2024-09-30¥4.9bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥4.9bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥2.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥5.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥5.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥274m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥274m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30¥73m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥727m
jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥2.7bn
jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥2.7bn
jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥1.5bn
jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥983m
jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥983m
jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥153m
—segment totalrevenue2023-04-01 → 2023-09-30¥3.7bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥3.7bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥4.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥1.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 447
ItemContextValueUnit
Net salesPrior1YTDDuration_ReportableSegmentsMember3706259000JPY
Net salesPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember274426000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember3980686000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration3980686000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E38215-000MedicalPlatformBusinessReportableSegmentsMember1470653000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E38215-000SmartClinicBusinessReportableSegmentsMember152680000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember1623333000JPY
Operating incomePrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember73342000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1696675000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-726928000JPY
Operating incomePrior1YTDDuration969747000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E38215-000MedicalPlatformBusinessReportableSegmentsMember3194205000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E38215-000SmartClinicBusinessReportableSegmentsMember1678026000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember4872232000JPY
Revenues from external customersCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember271159000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember5143392000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration5143392000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E38215-000MedicalPlatformBusinessReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E38215-000SmartClinicBusinessReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E38215-000MedicalPlatformBusinessReportableSegmentsMember3194205000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E38215-000SmartClinicBusinessReportableSegmentsMember1678026000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember4872232000JPY
Net salesCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember271159000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember5143392000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration5143392000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E38215-000MedicalPlatformBusinessReportableSegmentsMember1722871000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E38215-000SmartClinicBusinessReportableSegmentsMember394147000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember2117019000JPY
Operating incomeCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember64200000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember2181220000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-963515000JPY
Operating incomeCurrentYTDDuration1217704000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-11-13
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第20期中（自　2024年４月１日　至　2024年９月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社GENOVA
Company name in english cover pageFilingDateInstantGENOVA, Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　平瀬　智樹
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都渋谷区渋谷二丁目21番１号　渋谷ヒカリエ34F
Telephone number address of registered headquarter cover pageFilingDateInstant03-5766-1820

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass